Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · May 17, 2017

Keywords

ClinConnect Summary

This clinical trial is studying genetic factors related to pheochromocytomas and paragangliomas, which are types of tumors that can affect the nervous system and are often inherited. The researchers aim to identify specific genes that may be involved with these tumors and understand how different genetic backgrounds can influence the characteristics and behavior of the disease. This research is important because it can help doctors make better decisions about treatment and management for patients and their families.

To participate in this study, you may be eligible if you have been diagnosed with a pheochromocytoma or paraganglioma, or if you have a family member who has been diagnosed with one of these tumors or related conditions. Participants will undergo genetic testing to identify any mutations that may be present. It’s important to note that just because someone has a pheochromocytoma or paraganglioma, it doesn't mean a genetic mutation will always be found. This trial is currently recruiting participants of all ages and genders, and it aims to improve understanding and care for those affected by these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of pheochromocytoma and or paraganglioma
• • family member with diagnosis of pheochromocytoma and or paraganglioma
• • diagnosis of a pheochromocytoma- and or paraganglioma-associated condition
• • family member with diagnosis of a pheochromocytoma- and or paraganglioma-associated condition
• Exclusion Criteria:
• • unconfirmed diagnosis of pheochromocytoma and/or paraganglioma or associated condition